Deep Infiltrating Endometriosis : Laparoscopic Nerve-sparing Surgery and Use of Neutral Argon Plasma

Endometriosis Ovary Clinical Trial

— DIE  

Official title:

Deep Infiltrating Endometriosis : Laparoscopic Nerve-sparing Surgery and Use of Neutral Argon Plasma

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06207448
• Other study ID #: 8501
• Status: Completed
• Start date: April 1, 2022
• Est. completion date: June 6, 2022

Study information

• Verified date: December 2023
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Medical treatment of endometriosis has a suspensive and sometimes incomplete effect on the symptoms, making surgical treatment necessary. The aim of surgical treatment of deep endometriosis is to restore normal anatomy and functional integrity. Resection of deep endometriosis lesions is recommended to relieve pain, gynecological and digestive symptoms, but rarely urinary disorders. Nerve-sparing surgery, when feasible, reduces post-operative dysuria by sparing the lower hypogastric plexus.

The major limitations of these surgical procedures are the experience of the surgeon and the extent of the disease. Acquiring the surgical techniques and skills necessary to carry out these types of procedures is essential to providing optimal patient care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1
• Est. completion date: June 6, 2022
• Est. primary completion date: June 1, 2022
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult woman (=18 years old)

• Patient who benefited from treatment by nerve-sparing surgery and the use of neutral argon plasma in the context of symptomatic deep pelvic endometriosis at the Strasbourg University Hospital during 2021

• Patient who did not express, after information, the reuse of her data for the purposes of this research.

Exclusion Criteria:

• Patient who expressed her opposition to participating in the study

• Patient under legal protection, under guardianship or under curatorship

Related Conditions & MeSH terms

• Endometriosis
• Endometriosis Ovary

Locations

Country	Name	City	State
France	Service de Gynécologie Obstétrique - CHU de Strasbourg - France	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To retrospectively describe the minimally invasive management of deep pelvic endometriosis using nerve-sparing surgery and the use of neutral argon plasma for extensive endometriotic lesions by laparoscopy		up to 2 months